BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38063813)

  • 1. Robust incorporation of historical information with known type I error rate inflation.
    Calderazzo S; Wiesenfarth M; Kopp-Schneider A
    Biom J; 2024 Jan; 66(1):e2200322. PubMed ID: 38063813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
    Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
    Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflict.
    Calderazzo S; Wiesenfarth M; Kopp-Schneider A
    Biostatistics; 2022 Jan; 23(1):328-344. PubMed ID: 32735010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N; Liu C; Kim MO
    Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical bayes approach for dynamic bayesian borrowing for clinical trials in rare diseases.
    Sebastien B
    J Pharmacokinet Pharmacodyn; 2023 Dec; 50(6):495-499. PubMed ID: 37148459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
    Feißt M; Krisam J; Kieser M
    Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
    Kaplan D; Chen J; Yavuz S; Lyu W
    Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel power prior approach for borrowing historical control data in clinical trials.
    Shi Y; Li W; Liu GF
    Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A frequentist approach to dynamic borrowing.
    Li R; Lin R; Huang J; Tian L; Zhu J
    Biom J; 2023 Oct; 65(7):e2100406. PubMed ID: 37189217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
    Liu GF
    Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control.
    Kopp-Schneider A; Calderazzo S; Wiesenfarth M
    Biom J; 2020 Mar; 62(2):361-374. PubMed ID: 31265159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug development.
    Wu Y; Hui J; Deng Q
    Pharm Stat; 2020 Nov; 19(6):787-802. PubMed ID: 32573051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials.
    Hobbs BP; Carlin BP; Mandrekar SJ; Sargent DJ
    Biometrics; 2011 Sep; 67(3):1047-56. PubMed ID: 21361892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust meta-analytic-predictive priors in clinical trials with historical control information.
    Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
    Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.
    Spanakis E; Kron M; Bereswill M; Mukhopadhyay S
    J Biopharm Stat; 2023 Nov; 33(6):752-769. PubMed ID: 36507718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A frequentist design for basket trials using adaptive lasso.
    Kanapka L; Ivanova A
    Stat Med; 2024 Jan; 43(1):156-172. PubMed ID: 37919834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian clinical trial design using historical data that inform the treatment effect.
    Psioda MA; Ibrahim JG
    Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.